EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Healthcare Pattern of Use Before and After Initiating a Long-Acting Antipsychotic Among a Cohort of 6221 Patients With a History of Psychosis

Emmanuel Stip iD, Josiane Courteau, Sébastien Brodeur iD, Yohann M Chiu, Marie-Josée Fleury, Alain Lesage, Marc-André Roy iD

The Canadian Journal of Psychiatry · 2026

DOI: 10.1177/07067437261462697 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Canadian Journal of Psychiatry, 2026. Verfasst von Emmanuel Stip und 6 weiteren Autor:innen. Beteiligte Einrichtung: Département de Psychiatrie et d'Addictologie, Universite de Montreal Faculte de medecine, Montreal, Canada. Hauptthemen laut MEDLINE: Antipsychotic Agents, Psychotic Disorders, Schizophrenia, Patient Acceptance of Health Care. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Partenariat Innovation-Québec-Janssen (PIQJ) administered by the Quebec Health Research Funds, CR-IUSMM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate changes in antipsychotic treatment patterns and healthcare utilization before and after initiation of long-acting injectable antipsychotics (LAI-APs) in a large Québec population cohort, comparing individuals with schizophrenia (SCZ) to those with other psychotic disorders (non-SCZ).

Method

We conducted a retrospective cohort study using linked Québec administrative databases (RAMQ, MED-ECHO, and public drug insurance) to identify 6,221 adults who initiated a LAI-AP between April 2013 and December 2016, after a 12-month LAI-free period. Participants were followed for 12 months before and after the index date. The cohort was stratified into SCZ and non-SCZ, and were further divided by regimen at initiation (LAI only; LAI + clozapine; LAI + other oral antipsychotic). Antipsychotic exposure and health-service usage (hospitalizations, emergency visits, outpatient and community care) trajectories were analyzed weekly using state-sequence analysis; pre- versus post-initiation comparisons used paired statistical tests.

Results

Of 6,221 patients (63.4% male; mean age 41.6 years), initial treatments consisted of paliperidone LAI (55.7%), aripiprazole LAI (21.5%), risperidone LAI (6.9%), first-generation LAI (15.6%), and LAI combinations (0.2%); 40% received LAI only, 5% LAI + clozapine, 55% LAI + an oral antipsychotic. SCZ patients were more often male, economically disadvantaged, and more likely to receive clozapine. After LAI initiation, hospital days fell sharply by almost 70% and outpatient and community-care visits increased substantially. Use of oral antipsychotics decreased overall post-initiation, except for clozapine (which rose) and first-generation oral drugs (which remained stable).

Conclusions

In this real-world Québec cohort, LAI-AP initiation was followed by a marked reduction in hospitalizations and a shift toward outpatient and community care, regardless of diagnosis. Observed differences in sociodemographic and clinical profiles between SCZ and non-SCZ patients—and among SCZ treatment subgroups—suggest the need for tailored care pathways. These findings support LAI-AP effectiveness in reducing healthcare utilization and inform resource planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsPsychotic DisordersSchizophreniaPatient Acceptance of Health CareHospitalizationHumansMaleQuebecAdultFemaleRetrospective StudiesDelayed-Action PreparationsMiddle AgedClozapineCohort Studies

Stichwörter der Autor:innen

QAAPAPLE.community mental healthhealth services utilizationlong-acting injectable antipsychoticsreal-world cohortregistryschizophrenia

Substanzen

Antipsychotic AgentsDelayed-Action PreparationsClozapine

Autor:innen und Institutionen

  • Département de Psychiatrie et d'Addictologie, Universite de Montreal Faculte de medecine, Montreal, Canada.
  • Department of Psychiatry and Behavioral Science, College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Faculté de médecine et des sciences de la santé, Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS), Sherbrooke, Canada.
  • Département de Psychiatrie et Neurosciences, Université Laval, Québec, Canada.
  • Centre de Recherche CERVO, Université Laval, Québec, Canada.
  • Département de médecine de famille et de médecine d'urgence, Université de Sherbrooke, Sherbrooke, Canada.

ORCID-Profile: Emmanuel Stip, Sébastien Brodeur, Marc-André Roy

Förderung

  • Partenariat Innovation-Québec-Janssen (PIQJ) administered by the Quebec Health Research Funds
  • CR-IUSMM

Zitieren

APA

Stip, E., Courteau, J., Brodeur, S., Chiu, Y. M., Fleury, M. J., Lesage, A., & Roy, M. A. (2026). Healthcare Pattern of Use Before and After Initiating a Long-Acting Antipsychotic Among a Cohort of 6221 Patients With a History of Psychosis. The Canadian Journal of Psychiatry. https://doi.org/10.1177/07067437261462697

Vancouver

Stip E, Courteau J, Brodeur S, Chiu YM, Fleury MJ, Lesage A, et al. Healthcare Pattern of Use Before and After Initiating a Long-Acting Antipsychotic Among a Cohort of 6221 Patients With a History of Psychosis. The Canadian Journal of Psychiatry. 2026. doi:10.1177/07067437261462697

BibTeX
@article{Stip2026,
  author = {Stip, Emmanuel and Courteau, Josiane and Brodeur, Sébastien and Chiu, Yohann M and Fleury, Marie-Josée and Lesage, Alain and Roy, Marc-André},
  title = {Healthcare Pattern of Use Before and After Initiating a Long-Acting Antipsychotic Among a Cohort of 6221 Patients With a History of Psychosis},
  journal = {The Canadian Journal of Psychiatry},
  year = {2026},
  doi = {10.1177/07067437261462697}
}
Kostenlos starten →